Scholar Rock contends its experimental drug for spinal muscular atrophy can achieve what none of the currently available therapies can do to treat this rare disease. After positive data from a pivotal ...

In this episode of the MedCity Pivot Podcast, editor-in-chief Arundhati Parmar, speaks with Helix CEO James Lu about his company and how far precision medicine has come. All healthcare entities ...

The archaic practice of removing blood from the body to treat a wide range of illnesses lives on today as a standard treatment for certain blood disorders. The modern version of this approach, called ...

Philips is using its patient monitoring devices to help health systems deliver care more efficiently, especially in areas with specialist shortages. The company’s connected devices enable continuous ...

Empathy Health Technologies announced Wednesday that it raised $7.6 million to support its Sober Sidekick app, which helps prevent relapse by connecting those struggling with substance use disorder ...

One of the hotter areas of cancer drug research involves using a particular type of bispecific antibody as the backbone for therapeutic combinations intended to bring a multi-pronged attack to tumors.

A Pharvaris drug led to speedy relief and symptom resolution from the sudden swelling attacks caused by a rare genetic disorder, preliminary Phase 3 clinical trial results that pave the way for an FDA ...

The U.K. cost-effectiveness standard for drugs will increase by 25% in exchange for zero tariffs on the country’s ...

Americans largely trust their doctors but are skeptical of payers, drugmakers and hospital leadership — a divide fueled by ...

Immense economic pressure is mounting on cardiac clinics as providers face shrinking reimbursements and new payment models. Particularly for high-value cardiac device clinics and rhythm monitoring ...

In an interview, Munich Re Specialty Senior Vice President Jim Craig talked about the risk that accompanies innovation and the important role that insurers play.